A platform of conductive polymer-based sensors for selective and quantitative detection of opioids in biological samples

This technology is a flexible sensor that uses a special polymer film with tailored anchor molecules to detect and measure opioids like fentanyl and morphine in fluids such as sweat or blood by monitoring changes in electrical signals.

Background

The field of opioid detection and monitoring has become increasingly critical due to the ongoing opioid epidemic, which has resulted in significant public health and safety concerns worldwide. Opioids such as fentanyl and morphine are potent substances that, while medically valuable, are frequently misused, leading to overdoses and fatalities. Accurate, real-time monitoring of opioid levels in biological fluids is essential for clinical management of patients, law enforcement, and public health interventions. Traditional laboratory-based methods, such as mass spectrometry and immunoassays, are highly sensitive but require specialized equipment, trained personnel, and are not suitable for rapid, point-of-care, or field-based applications. This has created a pressing need for portable, user-friendly, and reliable technologies that can provide immediate and quantitative information about opioid exposure or misuse in a variety of settings.

Current approaches to opioid detection face several limitations that hinder their effectiveness in real-world scenarios. Laboratory-based techniques, while accurate, are time-consuming, expensive, and not easily accessible outside of specialized facilities. Immunoassay-based rapid tests, such as lateral flow strips, often suffer from cross-reactivity, limited specificity, and qualitative rather than quantitative results, making them less reliable for precise monitoring or distinguishing between different opioids. Additionally, many existing sensors lack the sensitivity required to detect low opioid concentrations in complex biological matrices like sweat, blood, or tears, and are prone to interference from other substances. Wearable or minimally invasive devices for continuous monitoring are rare, and those that exist are often bulky, uncomfortable, or insufficiently robust for practical use. These challenges underscore the need for innovative solutions that combine high sensitivity, selectivity, rapid response, and adaptability to various sample types and formats.

Technology

This technology is an advanced opioid detection sensor platform that utilizes a conductive polymer film, such as polyaniline, functionalized with covalently attached anchor molecules specifically designed to selectively adsorb target opioids like fentanyl or morphine. The film, with a thickness ranging from 10 to 500 μm, is deposited onto a working electrode and paired with a counter or reference electrode, all supported on either flexible or rigid substrates. When exposed to biological fluids or dissolved samples, the anchor molecules capture the opioid molecules, causing a change in the electronic properties and charge distribution of the polymer film. This interaction is detected as a measurable shift in electrical impedance—specifically, the phase angle—when an alternating current is applied. The platform is highly adaptable, supporting formats such as wearable patches for sweat analysis, test strips for liquid samples, and needle-based sensors for in vivo blood monitoring, making it suitable for clinical, forensic, and field applications.

What differentiates this technology is its combination of molecular selectivity, sensitivity, and versatility. The use of custom-designed anchor molecules covalently bound to the conductive polymer ensures high specificity for individual opioids, minimizing cross-reactivity and interference from other substances. The impedance-based detection method, particularly the focus on phase angle shifts, allows for rapid and quantitative measurement of opioid concentrations, following a predictable Langmuir adsorption isotherm for straightforward calibration. The modular design enables the sensor to function reliably in various sample matrices and physical formats, including flexible and robust devices that maintain performance even under mechanical stress. This adaptability, coupled with rapid response times and the ability to tailor the sensor for different opioids by simply changing the anchor molecule, positions the platform as a powerful, user-friendly solution for real-time opioid monitoring across a wide range of settings.

Benefits

  • Highly selective detection of specific opioids (e.g., fentanyl, morphine) using tailored anchor molecules
  • Rapid and sensitive quantification of opioid concentration via electrical impedance measurement
  • Versatile sensor formats including wearable patches, test strips, and needle sensors for diverse sample types
  • Capability to monitor opioids in various biological fluids such as sweat, blood, and tears
  • Robust performance with resistance to physical interference like bending in flexible devices
  • Adaptable fabrication methods enabling integration on flexible or rigid substrates
  • Enables point-of-care, clinical, and field applications for opioid monitoring and exposure detection

Applications

  • Wearable opioid monitoring patches
  • Point-of-care opioid test strips
  • In vivo opioid needle sensors
  • Field opioid detection kits

Additional info

This technology employs a conductive polymer film functionalized with specific anchor molecules like arginine to selectively adsorb opioids. Integrated onto electrodes, the film undergoes electronic property and charge delocalization shifts upon binding. These changes are transduced into measurable electrical impedance variations, specifically phase angle shifts proportional to analyte concentration. The platform enables rapid, sensitive quantification in biological fluids via wearable patches, test strips, or needle-based sensors.